Skip to main content

Table 2 Median (IQR) of the CTV Breast, BreastNearSkin, BreastNearCW, and CTV nodal coverage. The dose is displayed in percentage of the prescription dose

From: Dosimetric consequences of image guidance techniques on robust optimized intensity-modulated proton therapy for treatment of breast Cancer

Dosimetric parameters

Plan-O

Vplan-B

VPlan-T

VPlan-S

P values

Med

IQR

Med

IQR

Med

IQR

Med

IQR

Plan-O vs. Vplan-B

Plan-O vs. Vplan-T

Plan-O vs. Vplan-S

CTVbreast V90 (%)

99.7

99.3–99.8

98.8

98.7–99.6

99.6

98.6–99.6

99.6

98.6–99.8

0.22

0.34

0.60

CTVbreast V95 (%)

96.4

93.32–97.33

95.1

91.7–96.3

95.2

94.1–97.0

95.3

94.7–97.0

0.55

0.60

0.67

CTVbreast D90 (%)

96.5

95.4–97.5

96.3

95.3–97.5

96.4

95.6–97.3

96.4

95.7–97.5

0.75

0.80

0.93

CTVbreast D95 (%)

95.7

94.7–96.3

95.1

93.9–95.7

95.2

94.8–95.6;

95.2

94.9–95.7

0.22

0.45

0.55

CTV Breast D99 (%)

92.6

90.8–92.8

89.2

88.6–91.6

91.8

88.5–92.7

91.8

88.5–93.0

0.60

0.55

0.62

BreastNearCW V90 (%)

99.6

99.0–99.9

99.0

97.3–100

98.9

98.3–100

99.1

97.8–100

0.59

0.47

0.62

BreastNearCW V95 (%)

98.3

97.7–99.5

94.6

93.4–99.7

97.0

94.6–99.7

97.1

94.7–99.8

0.49

0.67

0.80

BreastNearCW D90 (%)

97.4

96.0–97.8

96.5

95.9–97.6

97.3

95.9–97.7

97.5

95.9–97.8

0.34

0.39

0.86

BreastNearCW D95 (%)

96.9

95.6–97.3

94.8

93.5–97.0

95.6

94.8–97.0

95.6

94.8–97.1

0.18

0.27

0.45

BreastNearSkin V90 (%)

99.4

98.5–99.5

98.7

98.3–99.5

98.9

97.2–99.6

99.1

97.2–99.6

0.49

0.95

0.84

BreastNearSkin V95 (%)

91.0

84.9–93.1

91.3

83.5–93.7

92.3

86.0–93.3

92.8

85.9–93.4

1.00

0.93

0.93

BreastNearSkin D90 (%)

95.5

94.1–96.0

95.2

93.6–96.4

95.5

94.2–95.7

95.2

94.2–96.0

1.00

0.81

0.98

BreastNearSkin D95 (%)

94.1

92.7–94.4

93.6

92.2–94.5

93.5

92.4–94.5

94.4

92.2–94.5

0.62

0.93

0.85

IMN D90 (%)

96.8

96.6–97.4

96.5

95.4–97.2

96.6

95.0–97.1

96.5

94.8–96.9

0.40

0.54

0.32

IMN D95 (%)

96.1

95.8–96.7

95.7

94.6–96.4

95.6

94.0–96.6

95.6

93.5–96.3

0.48

0.48

0.26

AXI D90 (%)

96.6

95.0–98.1

96.5

94.9–98.0

96.5

94.9–98.0

96.5

94.9–97.8

0.71

0.80

0.93

AXI D95 (%)

96.2

94.2–97.8

96.1

94.1–97.7

96.2

94.1–97.7

96.2

94.1–97.4

0.64

0.80

0.80

AXII D90 (%)

96.0

93.4–97.3

95.9

93.1–97.3

96.0

93.2–97.3

96.0

93.3–97.1

0.80

0.90

0.98

AXII D95 (%)

95.6

92.3–96.9

95.4

92.6–96.9

95.5

92.8–96.9

95.5

92.8–96.5

0.90

0.90

0.90

AXIII D90 (%)

96.4

93.6–97.1

96.3

93.7–97.0

96.1

94.0–97.0

96.2

93.8–97.0

0.80

0.71

0.90

AXIII D95 (%)

95.9

92.9–96.7

95.8

93.1–96.6

95.6

93.1–96.5

95.6

93.2–96.5

0.80

0.83

0.90

SCV D90 (%)

96.9

93.6–97.5

96.7

93.9–97.3

96.6

94.1–97.3

96.7

94.2–97.3

0.78

0.93

0.74

SCV D95 (%)

96.5

92.5–96.9

96.3

93.1–96.7

96.1

93.2–96.7

96.3

93.3–96.7

0.80

0.90

0.80

  1. Abbreviation: Med median; IQR interquartile range; BreastNearSkin, 1-cm rim of anterior CTV; BreastNearCW, 1-cm rim of posterior CTV